• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路托西汀A。一种天然存在的人类DNA拓扑异构酶I毒药。

Luotonin A. A naturally occurring human DNA topoisomerase I poison.

作者信息

Cagir Ali, Jones Shannon H, Gao Rong, Eisenhauer Brian M, Hecht Sidney M

机构信息

Department of Chemistry, University of Virginia, Charlottesville, Virginia 22901, USA.

出版信息

J Am Chem Soc. 2003 Nov 12;125(45):13628-9. doi: 10.1021/ja0368857.

DOI:10.1021/ja0368857
PMID:14599178
Abstract

Luotonin A is a pyrroloquinazolinoquinoline alkaloid isolated from the Chinese herbal medicinal plant Peganum nigellastrum. Although previously shown to exhibit cytotoxicity against the murine leukemia P-388 cell line, the mechanism of action of luotonin A is unknown. Presently, we demonstrate that luotonin A stabilizes the human DNA topoisomerase I-DNA covalent binary complex, affording the same pattern of cleavage as the structurally related topoisomerase I inhibitor camptothecin. Luotonin A also mediated topoisomerase I-dependent cytotoxicity toward Saccharyomyces cerevisiae lacking yeast topoisomerase I, but harboring a plasmid having the human topoisomerase I gene under the control of a galactose promoter. This finding identifies a putative biochemical locus for the cytotoxic action of luotonin A and has important implications for the mechanism of action of camptothecin and the design of camptothecin analogues.

摘要

路脱辛A是从中国草药植物骆驼蓬中分离出的一种吡咯并喹唑啉喹啉生物碱。尽管之前已显示出路脱辛A对小鼠白血病P - 388细胞系具有细胞毒性,但其作用机制尚不清楚。目前,我们证明路脱辛A可稳定人DNA拓扑异构酶I - DNA共价二元复合物,产生与结构相关的拓扑异构酶I抑制剂喜树碱相同的切割模式。路脱辛A还介导了对缺乏酵母拓扑异构酶I但含有在半乳糖启动子控制下具有人拓扑异构酶I基因的质粒的酿酒酵母的拓扑异构酶I依赖性细胞毒性。这一发现确定了路脱辛A细胞毒性作用的一个假定生化位点,对喜树碱的作用机制及喜树碱类似物的设计具有重要意义。

相似文献

1
Luotonin A. A naturally occurring human DNA topoisomerase I poison.路托西汀A。一种天然存在的人类DNA拓扑异构酶I毒药。
J Am Chem Soc. 2003 Nov 12;125(45):13628-9. doi: 10.1021/ja0368857.
2
Synthesis and biochemical properties of E-ring modified luotonin A derivatives.E环修饰的路托品A衍生物的合成及生化性质
Bioorg Med Chem Lett. 2004 May 3;14(9):2051-4. doi: 10.1016/j.bmcl.2004.02.069.
3
14-azacamptothecin: a potent water-soluble topoisomerase I poison.14-氮杂喜树碱:一种强效水溶性拓扑异构酶I毒药。
J Am Chem Soc. 2005 Jan 26;127(3):838-9. doi: 10.1021/ja0442769.
4
Synthesis and topoisomerase I inhibitory properties of luotonin A analogues.路脱宁A类似物的合成及其对拓扑异构酶I的抑制特性
Bioorg Med Chem. 2004 Dec 1;12(23):6287-99. doi: 10.1016/j.bmc.2004.08.052.
5
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.A环和E环取代的路脱宁A衍生物的合成及其对拓扑异构酶的中毒活性
Bioorg Med Chem. 2007 Jun 15;15(12):4237-46. doi: 10.1016/j.bmc.2007.03.067. Epub 2007 Mar 25.
6
Synthesis and cytotoxic activity of substituted luotonin A derivatives.取代路托品 A 衍生物的合成及细胞毒性活性
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5757-61. doi: 10.1016/j.bmcl.2004.09.039.
7
Regioselective quinazolinone-directed ortho lithiation of quinazolinoylquinoline: practical synthesis of naturally occurring human DNA topoisomerase I poison luotonin a and luotonins B and E.喹唑啉酮导向的喹唑啉酰基喹啉区域选择性邻位锂化反应:天然存在的人类DNA拓扑异构酶I抑制剂鲁托宁A以及鲁托宁B和E的实用合成方法
J Org Chem. 2004 Jun 25;69(13):4563-6. doi: 10.1021/jo040153v.
8
One-pot synthesis of luotonin A and its analogues.洛托辛 A 及其类似物的一锅合成。
Org Lett. 2011 Mar 4;13(5):920-3. doi: 10.1021/ol1029707. Epub 2011 Jan 26.
9
DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.来自岩黄连的DNA拓扑异构酶I抑制性生物碱。
Chem Biodivers. 2008 Jul;5(7):1335-44. doi: 10.1002/cbdv.200890121.
10
D-Ring-Modified Analogues of Luotonin A with Reduced Planarity: Design, Synthesis, and Evaluation of Their Topoisomerase Inhibition-Associated Cytotoxicity.D-环修饰的 Luotonin A 类似物,平面性降低:设计、合成及其拓扑异构酶抑制相关细胞毒性的评价。
Biomed Res Int. 2019 Nov 13;2019:2514524. doi: 10.1155/2019/2514524. eCollection 2019.

引用本文的文献

1
Natural Antifungal Alkaloids for Crop Protection: An Overview of the Latest Synthetic Approaches.用于作物保护的天然抗真菌生物碱:最新合成方法概述
Pharmaceuticals (Basel). 2025 Apr 18;18(4):589. doi: 10.3390/ph18040589.
2
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy.传统抗癌疗法的进展与局限:手术、化疗、放疗及激素疗法的全面综述
Discov Oncol. 2025 Apr 24;16(1):607. doi: 10.1007/s12672-025-02198-8.
3
Screening for antimicrobial and antioxidant activities of quinazolinone based isoxazole and isoxazoline derivatives, synthesis and In silico studies.
喹唑啉酮基异恶唑和异恶唑啉衍生物的抗菌和抗氧化活性筛选、合成及计算机模拟研究
Mol Divers. 2024 Nov 2. doi: 10.1007/s11030-024-11032-2.
4
Synthesis of -Alkyl Substituted Benzimidazoquinazolinones.α-烷基取代苯并咪唑喹唑啉酮的合成
ACS Omega. 2024 Jul 26;9(31):33805-33814. doi: 10.1021/acsomega.4c03327. eCollection 2024 Aug 6.
5
Recent Advances in the Research on Luotonins A, B, and E.罗托宁A、B和E的研究最新进展
Molecules. 2024 Jul 26;29(15):3522. doi: 10.3390/molecules29153522.
6
HO-Mediated Synthesis of a Quinazolin-4(3)-one Scaffold: A Sustainable Approach.通过HO介导合成喹唑啉-4(3)-酮骨架:一种可持续的方法。
ACS Omega. 2023 Aug 30;8(36):33058-33068. doi: 10.1021/acsomega.3c05162. eCollection 2023 Sep 12.
7
Recent Advances in the Green Synthesis of Active -Heterocycles and Their Biological Activities.活性杂环化合物的绿色合成及其生物活性的最新进展
Pharmaceuticals (Basel). 2023 Jun 13;16(6):873. doi: 10.3390/ph16060873.
8
One-Pot Synthesis of Isoxazole-Fused Tricyclic Quinazoline Alkaloid Derivatives via Intramolecular Cycloaddition of Propargyl-Substituted Methyl Azaarenes under Metal-Free Conditions.一锅法合成异恶唑并三环喹唑啉生物碱衍生物:无金属条件下炔丙基取代甲基氮杂芳烃的分子内环加成反应。
Molecules. 2023 Mar 20;28(6):2787. doi: 10.3390/molecules28062787.
9
A Computational QSAR, Molecular Docking and In Vitro Cytotoxicity Study of Novel Thiouracil-Based Drugs with Anticancer Activity against Human-DNA Topoisomerase II.一种新型基于硫代尿嘧啶的具有抗癌活性的人源 DNA 拓扑异构酶 II 的计算定量构效关系、分子对接和体外细胞毒性研究。
Int J Mol Sci. 2022 Oct 5;23(19):11799. doi: 10.3390/ijms231911799.
10
..
J Org Chem. 2022 Oct 7;87(19):13023-13033. doi: 10.1021/acs.joc.2c01561. Epub 2022 Sep 12.